ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,680 | +74.0% | 2,000 | +100.0% | 0.00% | 0.0% |
Q2 2023 | $23,950 | +27.3% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $18,820 | +18.2% | 1,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $15,920 | -0.5% | 1,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $16,000 | +14.3% | 1,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $14,000 | -41.7% | 1,000 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $24,000 | +4.3% | 1,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $23,000 | -8.0% | 1,000 | -33.7% | 0.00% | 0.0% |
Q3 2021 | $25,000 | -32.4% | 1,508 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $37,000 | -5.1% | 1,508 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $39,000 | -51.9% | 1,508 | 0.0% | 0.00% | -57.1% |
Q4 2020 | $81,000 | +30.6% | 1,508 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $62,000 | +158.3% | 1,508 | +201.6% | 0.01% | +133.3% |
Q2 2020 | $24,000 | +14.3% | 500 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $21,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |